Mitsuharu Masuda

Kyoto, 6028566, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Terminalagin, a New Ellagitannin from Kakadu Plum (Terminalia ferdinandiana).

Terminalagin, a New Ellagitannin from Kakadu Plum (Terminalia ferdinandiana).

Journal: Chemical & pharmaceutical bulletin

Published: December 14, 2025

Design, synthesis, and biological evaluation of phenylcyclopropylamine-entinostat conjugates that selectively target cancer cells.

Design, synthesis, and biological evaluation of phenylcyclopropylamine-entinostat conjugates that selectively target cancer cells.

Journal: Bioorganic & medicinal chemistry

Published: December 23, 2023

Discovery of Selective Histone Deacetylase 1 and 2 Inhibitors: Screening of a Focused Library Constructed by Click Chemistry, Kinetic Binding Analysis, and Biological Evaluation.

Discovery of Selective Histone Deacetylase 1 and 2 Inhibitors: Screening of a Focused Library Constructed by Click Chemistry, Kinetic Binding Analysis, and Biological Evaluation.

Journal: Journal of medicinal chemistry

Published: October 17, 2023

Discovery of cancer-preventive juices reactivating RB functions.

Discovery of cancer-preventive juices reactivating RB functions.

Journal: Environmental health and preventive medicine

Published: September 24, 2023

Induction of MYCN-amplified neuroblastoma differentiation through NMYC suppression using PPAR-γ antagonist.

Induction of MYCN-amplified neuroblastoma differentiation through NMYC suppression using PPAR-γ antagonist.

Journal: Journal of clinical biochemistry and nutrition

Published: April 27, 2023

Cancer-Cell-Selective Targeting by Arylcyclopropylamine-Vorinostat Conjugates.

Cancer-Cell-Selective Targeting by Arylcyclopropylamine-Vorinostat Conjugates.

Journal: ACS medicinal chemistry letters

Published: March 18, 2022

A chemoproteoinformatics approach demonstrates that aspirin increases sensitivity to MEK inhibition by directly binding to RPS5.

A chemoproteoinformatics approach demonstrates that aspirin increases sensitivity to MEK inhibition by directly binding to RPS5.

Journal: PNAS nexus

Published: October 30, 2021

Design, synthesis and evaluation of γ-turn mimetics as LSD1-selective inhibitors.

Design, synthesis and evaluation of γ-turn mimetics as LSD1-selective inhibitors.

Journal: Bioorganic & medicinal chemistry

Published: November 24, 2017

Targeting Cancer with PCPA-Drug Conjugates: LSD1 Inhibition-Triggered Release of 4-Hydroxytamoxifen.

Targeting Cancer with PCPA-Drug Conjugates: LSD1 Inhibition-Triggered Release of 4-Hydroxytamoxifen.

Journal: Angewandte Chemie (International ed. in English)

Published: September 06, 2016

C-H activation enables a rapid structure-activity relationship study of arylcyclopropyl amines for potent and selective LSD1 inhibitors.

C-H activation enables a rapid structure-activity relationship study of arylcyclopropyl amines for potent and selective LSD1 inhibitors.

Journal: Organic & biomolecular chemistry

Published: August 23, 2016

Inhibition by polyphenolic phytochemicals and sulfurous compounds of the formation of 8-chloroguanosine mediated by hypochlorous acid, human myeloperoxidase, and activated human neutrophils.

Inhibition by polyphenolic phytochemicals and sulfurous compounds of the formation of 8-chloroguanosine mediated by hypochlorous acid, human myeloperoxidase, and activated human neutrophils.

Journal: Bioscience, biotechnology, and biochemistry

Published: December 11, 2012

Showing 1-11 of 11

Last Updated: 09/26/2026